Torres, Antoni
Motos, Anna
Battaglini, Denise
Li Bassi, Gianluigi
Article History
Received: 13 December 2017
Accepted: 16 January 2018
First Online: 17 December 2018
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Gianluigi Li Bassi and Antoni Torres have received, through their affiliated institution, research funds from Bayer HealthCare Pharmaceuticals LLC (Germany), the manufacturer of NKTR-061 and BAY41–6551, and Cardeas (USA), the manufacturer of the combination amikacin-fosfomycin inhaled solution. None of the remaining authors have any potential conflict of interest related to the main topic of this article.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.